The preparation and mouse evaluation of nonviable, solvent-extracted antituberculous vaccines: (a) main assay findings; (b) stability of nonviable vaccines; (c) a major disadvantage of intravenous challenge.
D000818:Animals; D001500:BCG Vaccine; D001681:Biological Assay; D004339:Drug Compounding; D005069:Evaluation Studies as Topic; D006168:Guinea Pigs; D051379:Mice
D001500:BCG Vaccine